白细胞介素4及其在病毒性肝炎中的作用

黄俊华; 唐宝章

白细胞介素4及其在病毒性肝炎中的作用

1. 武警云南总队医院传染病科
2. 昆明医学院第一附属医院传染科

详细信息

中图分类号: R512.6
计量
- 文章访问数: 3059
- HTML全文浏览量: 1
- PDF下载量: 968
- 被引次数: 0
出版历程
- 出版日期: 2007-02-20

摘要

HTML全文

参考文献(16)

[1]Ihle N.The Stat family in cytokine signaling[J].Current opinion incell biology, 2001, 13∶211-217.

[2]Khayyamian S, Hutloff A, Buchner K, et al.ICOS-ligand, ex-pressed on human endothelial cells, costimulates Th1 and Th2 cyto-kine secretion by memory CD4+Tcells[J].Proceedings of the Na-tional Academy of Sciences of the United States of America, 2002, 99∶6198-6203.

[3]Penna A, Del Prete G, Cavalli A, et al.Predominant T-helper 1cytokine profile of hepatitis B virus nucleocapsid-specific Tcells inacute self-limited hepatitis B[J].Hepatology, 1997, 25∶1022-1027.

[4]邢同京, 章廉, 卢桥生, 等.慢性乙型肝炎用干扰素治疗的Th1/Th2应答[J].中华医学杂志, 2000, 50 (4) ∶1001-0939.

[5]Marines G, Rossol S, Carucci P, et al.Immunopathogenesis of hep-atitis B virus recurrence after liver transplantation[J].Transplanta-tion, 2000, 69∶559-568.

[6]Bertoletti A, D'Elios MM, Boni C, et al.Different cytokine profilesof intrehepatic Tcell in chronic hepatitis B and hepatitis C virus in-fections[J].Gastroenterology, 1997, 112∶193.

[7]Nishimura T, Ohta A.A critical role for antigen-specific Th1 cellsin acute liver injury in mice[J].J Immunol, 1999, 162∶6503.

[8]唐宝璋, 陈皋, 陈红英, 等.重型肝炎患者血清内毒素、白细胞介素 (IL) -4、IL-18水平的研究[J].中华内科杂志, 2004, 43 (2) ∶137-138.

[9]Milich DR, Chen MK, Hughes JL, et al.The secreted hepatitis Bprecore antigen can modulate the immune response to the nucleocap-sid:a mechanism for persistence[J].J Immunol, 1998, 160∶2013-2021.

[10]Cobb MH.MAP kinase pathways[J].Progress in biophysics andmolecular biology, 1999, 71∶479-500.

[11]Goff W L, Johnson W C, Parish S M, et al.IL-4 and IL-10 in-hibition of INF-gamma and TNF-alpha-dependent nitric oxideproduction from bovine mononuclear phagocytes exposed to Babesiabovis merozoites[J].Veterinary immunology and immunopathology, 2002, 84∶237-251.

[12]Rodriguez-Calvillo M, Duarte M, Tirapu I, et al.Upregulation ofnatural killer cells functions underlies the efficacy of intratumorallyinjected dendritic cells engineered to produce interleukin-12[J].Experimental hematology, 2002, 30∶195-204.

[13]Piazzolla G, Tortorella C, Schiraldi o, et al.Relationship betweeninterferon-gamma, interleukin-10 and interleukin-12 productionin chronic hepatitis C and in vitro effects of mterferon-alpha[J].JClin Immunol, 2000, 20∶54-61.

[14]Harraga S, Godot V, Bresson-Hadni S, et al.Clinical efficacy ofand switch from Thelper 2 to Thelper 1 cytokine profile after inter-feron alpha2a monotherapy for human echinococcosis[J].Clinical in-fectious diseases, 1999, 29∶205-206.

[15]Higashi N, Nakamuta M, Motomura K, et al.Serum level of inter-leukin-4 is a possible marker of therapeutic response to interferontreatment in patients with chronic hepatitis C[J].Journal of hepatolo-gy, 1999, 31∶383.

[16]Otsubo H, Kaito K, Ogasawara YoJi, et al.Successful immunosup-pressive therapy with cyclosporine A for posthepatitis B-cell defi-ciency with activated cytoplasmic interferon-gammapositive T-lym-phocytes[J].International Journal of Hematology, 2002, 75∶285-288.

施引文献

资源附件(0)

访问统计